GAO: FDA’s Device Recall Oversight in Need of Reform

The FDA should launch a program to routinely and systematically assess device recall information, and use this to identify strategies for mitigating health risks presented by defective or unsafe devices, the Government Accountability Office (GAO) says.
The GMP Letter